FDA has identified condition-specific medication health fraud scams that can pose significant risks to consumers.
Similar Posts
Central Admixture Pharmacy Services Inc. Allentown, PA. 483 issued 09/05/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/05/2025
Short Title (70 char) Central Admixture Pharmacy Services Inc. Allentown, PA. 483 issued 09/05/2025
FEI Number 3009590582
Firm Name Central Admixture Pharmacy Services Inc
Record Type 483
State PA
Est2024 First Generic Drug Approvals
2024 First Generic Drug ApprovalsUltra Seal Corporation – 624650 – 09/25/2024
CGMP/Finished Pharmaceuticals/AdulteratedInformation for Consumers and Patients | Drugs
Drug Information for Patients and ConsumersNorth American Custom Laboratories LLC dba FarmaKeio Superior Custom Compounding. Richardson, TX. 483 issued 09/05/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/05/2025
Short Title (70 char) North American Custom Laboratories LLC dba FarmaKeio Superior Custom Compounding. Richardson, TX. 483 issued 09/05/2025
FEI Number 3014229024
Firm Name North American Custom LaboFDA alerts drug manufacturers to the risk of benzene contamination in certain drugs
FDA is evaluating the root cause of benzene contamination in certain drugs and alerting drug manufacturers to the risk of benzene contamination from drug components and other potential risk factors
